Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | NAD(P)H dehydrogenase, quinone 2 | Starlite/ChEMBL | References |
Homo sapiens | melatonin receptor 1B | Starlite/ChEMBL | References |
Homo sapiens | melatonin receptor 1A | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | melatonin receptor 1B | 362 aa | 329 aa | 18.8 % |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | NAD(P)H dehydrogenase, quinone 2 | 231 aa | 213 aa | 26.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 1 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 10.05 | Displacement of [125I]iodomelatonin from MT3/QR2 melatonin binding site expressed in CHO cells | ChEMBL. | 18400335 |
Ki (binding) | = 0.047 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1B expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 0.047 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1B expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 0.08 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1A expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 0.08 nM | Inhibition of 2-[125I]-iodomelatonin binding to human Melatonin receptor type 1A expressed in HEK293 cells | ChEMBL. | 11960497 |
Ki (binding) | = 0.088 nM | Inhibition of 2-[125I]-iodomelatonin binding to Melatonin receptor 3 (MT3) of Syrian hamster brain membrane | ChEMBL. | 11960497 |
Ki (binding) | = 0.088 nM | Inhibition of 2-[125I]-iodomelatonin binding to Melatonin receptor 3 (MT3) of Syrian hamster brain membrane | ChEMBL. | 11960497 |
Selectivity (binding) | = 0.53 | Selectivity ratio of binding affinity at MT2 receptor relative to MT3 receptor | ChEMBL. | 11960497 |
Selectivity (binding) | = 0.9091 | Selectivity ratio of binding affinity at MT1 receptor relative to MT3 receptor | ChEMBL. | 11960497 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.